Liver Cancer

>

Latest News

Survival results from the phase 3 CheckMate –9DW trial support the application for the combination therapy in treating hepatocellular carcinoma.
EMA Validates Application for Nivolumab/Ipilimumab in Liver Cancer Type

July 22nd 2024

Survival results from the phase 3 CheckMate –9DW trial support the application for the combination therapy in treating hepatocellular carcinoma.

Findings from a retrospective study showed that outpatient robotic hepatectomies resulted in no mortalities across 307 procedures.
Robotic Hepatectomy May Demonstrate Safety in Liver Cancer

June 20th 2024

Investigators of the HEPATORCH trial will present additional data on toripalimab plus bevacizumab in this population at a future academic conference.
Toripalimab Combo May Improve Survival Vs Sorafenib in Advanced HCC

June 13th 2024

The 5-year follow-up results from CheckMate 040 showed consistent responses with nivolumab/ipilimumab in advanced hepatocellular carcinoma.
Nivolumab/Ipilimumab Yields Sustained Responses in Advanced HCC

May 30th 2024

The agency issues a complete response letter for the combination due to deficiencies associated with a manufacturing site inspection.
FDA Sends CRL for Camrelizumab/Rivoceranib in Unresectable Liver Cancer

May 20th 2024

Video Series
Video Interviews
Podcasts
Govindarajan Narayanan, MD, speaks to the potential time-saving advantages of using the Epione robot for microwave ablation, cryoablation, and other surgical strategies in patients with liver cancer and other tumors.

More News